Children With Medical Complexity: An Emerging Population for Clinical and Research Initiatives

Abstract
Children with medical complexity (CMC) have medical fragility and intensive care needs that are not easily met by existing health care models. CMC may have a congenital or acquired multisystem disease, a severe neurologic condition with marked functional impairment, and/or technology dependence for activities of daily living. Although these children are at risk of poor health and family outcomes, there are few well-characterized clinical initiatives and research efforts devoted to improving their care. In this article, we present a definitional framework of CMC that consists of substantial family-identified service needs, characteristic chronic and severe conditions, functional limitations, and high health care use. We explore the diversity of existing care models and apply the principles of the chronic care model to address the clinical needs of CMC. Finally, we suggest a research agenda that uses a uniform definition to accurately describe the population and to evaluate outcomes from the perspectives of the child, the family, and the broader health care system.
Since 1998, the Maternal and Child Health Bureau has defined children with special health care needs (CSHCN) as those children who have or are at increased risk of a chronic physical, developmental, behavioral, or emotional condition and require health care and related services of a type or amount beyond that required by children generally.1 An extensive process informed the development of an intentionally broad and inclusive CSHCN definition for the definition to be meaningful for broad program planning and development. Although 13% to 18% of children are considered to have special needs (excluding those who are “at risk” for special needs),2 there is considerable variation in medical complexity, functional limitations, and resource need among CSHCN.3,4 One important subgroup is the children who are the most medically fragile and have the most intensive health care needs. Examples vary and include children who have a congenital or acquired multisystem disease, a severe neurologic condition with marked functional impairment, or patients with cancer/cancer survivors with ongoing disability in multiple areas. Terms traditionally used to describe this subgroup include a combination of children with 1 or more of the following terms: complex, chronic, medical, conditions, and/or needs (eg, complex chronic conditions [CCCs],5 complex medical needs,6 complex medical conditions,7 and complex health conditions8), as well as medically complex children.9,10 In this article, we use the term “children with medical complexity” (CMC). The rationales are that it uses “person-first” terminology and refers to the extra time, expertise, and resources necessary to achieve optimal health outcomes for these children.
CMC are likely increasing in prevalence because of increased survival rates of infants born prematurely,11 those born with various congenital anomalies,12,13 and/or those with chronic conditions, as well as improved treatments for acute illnesses in fields such as intensive care14 and oncology.15 These medical successes in survivorship have likely also resulted in rising rates of complications and childhood disability,16,17 with subsequent increases in intensive medical technology use,18 medical and nursing care,19 and coordination needs.20 Regardless of underlying diagnoses, all CMC share similar functional and resource-use consequences, including (1) intensive hospital- and/or community-based service need, (2) reliance on technology, polypharmacy, and/or home care or congregate care to maintain a basic quality of life, (3) risk of frequent and prolonged hospitalizations, which leads to high health-resource utilization, and (4) an elevated need for care coordination.21 The need to coordinate care for CMC has been underscored by the recent emergence of numerous novel complex care programs across North America that address the service needs of CMC in a variety of inpatient, outpatient, and community-based settings.10,22,–,24 However, meaningful evaluation of the outcomes of these and other programs is limited by a lack of agreement on a definition of CMC and the absence of a clinical and research agenda. The objectives of this article are to (1) present a definitional framework for describing CMC and (2) propose a clinical and research agenda for a model of service delivery that is aimed at improving the quality of health care for CMC and their families.
DEFINITIONAL FRAMEWORK OF CMC
Despite recent attention focused on CMC in the clinical setting, there are considerable inconsistencies in the way these children are defined in the research literature. Clinical and research initiatives would benefit from the use of a uniform definition that is clear, reproducible, and comparable across studies. This definition should be able to consistently identify children whose health and quality of life depend on integrating health care between a primary care medical home, tertiary care services, and other important loci of care such as transitional care facilities, rehabilitation units, the home, the school, and other community-based settings. The threshold for definition of CMC may be context-specific; definitions used in epidemiologic studies may differ from enrollment criteria for inclusion in clinical programs in different locales depending on resource availability, alternative models of care, and the specific family situation. Additional issues to address in operationalizing a definition for CMC include the periodicity of assessments, because complexity of care needs may change over time, as well as the mechanism to identify such patients (eg, individual providers, systems of care, parental reports, etc).
Our definitional framework adapts recommendations from a recent systematic review of chronic disease of childhood (Fig 1).25 In this review, we propose a framework of 4 broad domains to characterize chronic conditions of childhood: needs; chronic conditions; functional limitations; and health care use. Conceptually, the combination of specific manifestations of each of these 4 domains encompasses the collective features of CMC.
Needs: CMC are characterized by substantial family-identified health care service needs such as medical care, specialized therapy, and educational needs. The service needs have a significant impact on the family unit, specifically time devoted to direct care, frequent provider visits, care coordination, and financial burden. The type, intensity, and consistency of these manifestations may change dynamically over the life of the child depending on a variety of medical, psychosocial, and community factors.
Chronic condition(s): CMC have 1 or more chronic clinical condition(s), either diagnosed or unknown, that are severe and/or associated with medical fragility (eg, high morbidity and mortality rates). The condition and/or its sequelae should be expected to be potentially lifelong, although some children may improve with optimal care or with time. Examples may include a known condition identified among an established list of CCCs.26 An unknown but suspected complex and chronic condition, such as a child born with multiple congenital anomalies but lacking a unifying diagnosis, would be included.
Functional limitations: Functioning is typically classified by using key dimensions of body structure and function, performance of activities, and participation in communal life.27,28 For CMC, the limitations are typically severe and may require assistance from technology such as a tracheostomy tube, feeding tube, or a wheelchair. The type, consistency, and severity of functional limitations may vary over the life of the child in the context of environmental and personal factors.
Health care use: CMC typically have high projected utilization of health resources that may include frequent or prolonged hospitalization, multiple surgeries, or the ongoing involvement of multiple subspecialty services and providers. The intensity of health care use may also vary over time but is anticipated to be substantial when compared with other populations of CSHCN.
Clinical examples of CMC are described in the Appendix.
Our 4 domains complement the existing literature on CMC. Previous definitions lacked at least 1 domain, in part because of the data source or a particular focus such as family-identified needs, diagnostic and procedural codes, functional limitations, and resource use.
The National Survey of Children With Special Health Care Needs (NS-CSHCN) assesses family-reported need and enables state-level prevalence estimates and descriptions of CSHCN.29 One report described rising complexity by an increasing number of affirmative answers to 5 screening questions that identify special needs; there was a resultant upward trend in costs and service needs.3 The NS-CSHCN inquires about 16 common health conditions, the presence of 14 different functional limitations, and the use of numerous specific types of health services that may capture CMC. Although the condition list may detect many of the comorbidities among CSHCN, the NS-CSHCN lacks information about less common primary medical conditions that may be important contributors to the child's complexity, the duration, frequency, and severity of underlying chronic health issues, and specific details on functional limitations (such as technology dependence) and intensive service use, which may better capture and describe this key population.
In 2000, Feudtner et al26 compiled a list of International Classification of Diseases, Ninth Revision–coded “complex chronic conditions” (CCCs) based on an operational definition of a medical condition that lasts for >12 months and involves several different organ systems or 1 organ system requiring a high level of specialty care and hospitalization. Examples of CCCs include brain and spinal cord malformations, metabolic disorders, cardiac and respiratory malformations, and malignancies. CCCs account for 2.3% of all newborn discharges from hospitals in Ontario, Canada,30 as well as an increasing proportion of childhood deaths26 and pediatric hospital care.31 There are limitations to approaches that rely exclusively on diagnostic codes. CCCs were not designed to describe the interaction of the condition with needs, functional limitations, and health care use. Thus, a particular CCC (eg, cystic fibrosis) can include children ranging from those who are virtually asymptomatic, and therefore unlikely to meet criteria to be considered CMC, to those with severe functional impairment who spend large portions of their lives interfacing with the health care system and would fulfill criteria for CMC. CCCs may also exclude children whose condition(s) is not defined by a particular coded diagnosis.
Other definitions of complexity focus on descriptions of functional domains and fragility in keeping with the World Health Organization's framework for classifying impairments, disabilities, and handicaps. These definitions include terms such as (1) children with multiple impairments (those with “significant physical disabilities combined with sensory and/or cognitive deficits”),1 (2) the technology-dependent child (“a child who requires both a medical device to compensate for the loss of a vital body function and significant and sustained care to avert death or further disability”),32 (3) the medically fragile child (who is either technology dependent or “requires substantial ongoing nursing care to avert death or further disability”),33 and (4) children with complex needs (“children with multiple health/developmental needs that require multiple services from multiple sectors, in multiple locations”).33 Of these definitions, medical technology dependence on devices such as a tracheostomy or enteral feeding tube has been most frequently used but by itself may only identify a smaller subpopulation of CMC.34
Lastly, administrative data have been used to profile resource use by classifying people into a health-status group and a severity level. Neff et al35,36 identified medically extreme “catastrophic” patients as having chronic conditions that are expected to be lifelong and progressive and to require extensive services. Examples of catastrophic conditions included quadriplegia, cystic fibrosis, and spina bifida. This “catastrophic” category comprised only 0.4% of the children but was responsible for 11% of health care charges and 24% of all pediatric hospital charges. However, in a follow-up article, Neff et al37 noted that only half of “catastrophic” children in a given year were identified because of the varying utilization between different years.
In sum, although a variety of definitions exist that capture 1 or more of the domains of CMC, each has its limitations. A definitional framework that captures needs, chronic conditions, functional limitations, and health care use is necessary to accurately describe this population of children and to develop interventions to improve their outcomes.
CLINICAL AGENDA
Despite the relatively small numbers of CMC, the impact of suboptimal care for these children on their health, their family's well-being, and the health care system is substantial. It is not surprising that in 2003 the Institute of Medicine identified CSHCN as a priority for national action and emphasized the impact of those with substantial medical problems.38
The evidence from examinations of clinical models of effective and efficient provision of health care for CMC remains remarkably limited. Existing care models include medical homes, comanagement, and hospital-based and hybrid models that focus on care coordination. Reports from several mainly uncontrolled studies have described the medical home,39,–,42 hospital-based programs,10,24,43 hospital-to-medical home transitions,22 home care,44,–,48 tele-home care,59 and disease-specific specialty clinics (eg, cystic fibrosis,50 epilepsy,51 and sickle cell disease52). Adult providers are also developing adult complex care models.53 The care models all typically provide enhanced care coordination and/or condition-specific expertise.
The medical home model, with the primary care physician as the central hub for care coordination, has been espoused as ideal for the care of CSHCN. However, implementation for CMC has been limited,54 likely because of time restrictions, inadequate payment, and lack of decision-making support for primary care providers. Many subspecialty care clinics are restricted to patients who fit a specific diagnosis; tertiary care complex care models provide enhanced decision-making support and care coordination at the hospital but can subsume care away from the community-based medical home.
A clinical agenda focused on an optimal model of care for CMC can be informed by the principles of the chronic care model (CCM) created by Wagner et al.55,56 The CCM has received considerable recent support in the literature as a framework for system-based reform.57 The CCM espouses health system redesign and emphasizes family/provider partnerships, improved self-management, and decision-making support by primary care providers. In accordance with the CCM, the ideal care model for CMC addresses each of the elements that define CMC. Specific components within the 4 domains of the definitional framework include:
Needs: a family-centered system of care that provides accessible health care services as well as information to families and empowers families in self-management. Provider uptake of the principles of family-centered care and inclusion of families as advisors to system redesign are crucial.
Chronic conditions: sufficient knowledge, understanding, and decision-making support across the entire continuum of care including both the community and tertiary care levels. In particular, ongoing education or support to primary care providers on the care requirements of the child or population may be necessary.
Functional limitations: ensuring availability of supports for the family and community, including necessary medical technology for maximization of functioning within the key dimensions of body structure and function, performance of activities, and participation in communal life.27
Health care use: a care-delivery system that prioritizes high-quality and efficient care through enhanced care coordination and clearly defined provider roles across different settings.
Creating care models for CMC requires champions across a variety of settings to implement a quality-improvement agenda. Initial efforts can be focused on single or bundled quality-improvement implementation tools. Examples include care plans, dedicated care coordinators, targeted patient-safety initiatives (eg, enhanced medical reconciliation), and/or provider education (eg, best practices for specific procedures or complications). Shared decision-making aids are another potentially useful tool that can help patients and families make value-based informed choices among relevant health care options.58 The frequent interface that these children have with the medical system also provides an opportunity to target patient-safety enhancements such as reduction of medical59 and medication60 errors. New services dedicated to CMC need to take into account the local facilities, expertise, existing care access, and community resources for CMC. Specific issues to address include the roles of complex care services and referring providers; the technical expertise, knowledge, and after-hours availability required of such services, particularly in the primary care setting; and communication tools, including referral forms, integrated electronic medical records, and communication between providers, needed to create a seamless and effective plan of care.
Providers for and families of CMC should advocate to hospitals, payers, and policy leaders for the priority of CMC as a target population for system reform. However, advocacy for CMC should not preclude advocacy for all CSHCN, because suboptimal systems performance is common for CSHCN. Such advocacy may include funding for dedicated clinical services; community provider information support; communication tools; and increased advisory roles and partnership by families. Care for complex and chronic illness is complicated by health care payment, which provides incentives for volume and procedures among physicians at the expense of care coordination, expanded nursing roles, and home care.61 Excessive hospital-based resource utilization has been used to justify development of complex care services.62 Although there has been no known controlled trial of dedicated complex care service provision for children, results of preliminary studies have shown potential for substantial cost savings by decreasing utilization of hospital days through care-coordination interventions.10,24,63,–,65 A key clinical and research priority that has yet to be addressed is the use of alternative payment models to reduce costs and improve quality for CMC.
RESEARCH AGENDA
The Institute of Medicine has identified the comparative effectiveness of programmatic models in severe chronic disease as a priority area of research.66
To date, the definitions, designs, and outcomes of evaluation studies for CMC vary markedly. A focused research agenda on CMC must operationalize the definitional framework found in Fig 1 into tools that are reliable, valid, and feasible. Most administrative data sets cannot fully capture CMC and will almost certainly be limited in scope if they cannot incorporate family-identified needs and functional limitations. However, adaptation of existing instruments such as adding questions that capture elements of our definitional framework to the NS-CSHCN may help achieve this goal, particularly if it is augmented by linked data from health administrative data sets and/or instruments completed by providers to create a complexity scale.
Improvement science that addresses the care of CMC needs to link the clinical interventions being assessed (eg, models of care, care plans, reimbursement strategies) with important and measurable outcomes. Examples of such outcomes should reflect the definitional framework of CMC, specifically meeting family-identified needs, reducing condition-specific health complications, addressing functional limitations, and reducing unnecessary health service use, including emergency department visits, hospitalization days, readmissions, and cost of total care. Outcomes should discriminate between whether the intervention is condition-specific or condition-independent. Some existing literature focuses on condition-specific interventions and outcomes common to many CMC. Examples include comparative effectiveness of treatments for particular subgroups of children (eg, gastroesophageal reflux disease and comparative antireflux procedures for children with neurologic impairment).67,68 It is unfortunate that CMC are often excluded from condition-specific studies because of the rarity of underlying conditions, disease severity, and/or multiple comorbidities.69
Studies that focus on condition-independent outcomes could include measures of perceptions of health care quality or health-related quality of life, both of which are particularly important for a group of children who interface so frequently with the medical system. Mental health should also be measured as salient outcomes, because psychiatric issues are common in many CMC.70 Because of the potent and pervasive impact of complex conditions on families and parental caregivers, including enhanced stress,71 poor health,72,73 marital discord,74 and employment and financial consequences,75 families should be actively involved in the research process and help inform the selection of important family-based outcomes. Examples of family-based outcomes include caregiver health and quality of life, family functioning and resiliency, the effects on siblings, and/or financial impact. Other condition-independent outcomes include integration and participation in the community76 and family knowledge about and utilization of their child's medical care and community resources. Careful consideration should be given in all studies of condition-independent outcomes in CMC to appropriate comparison groups, including both children with and without special health care needs. Outcome measures should encompass the holistic International Classification of Functioning, Disability and Health definition of functioning, disability, and health,27,28 which includes domains that may (eg, body structure and function) or may not (eg, activities and participation) be permanently impaired among some CMC. For the many CMC with life-limiting conditions, key processes of care such as the availability of palliative care, end-of-life care, advanced directives, and accessibility to hospice care should be addressed as well.
Finally, critical goals for all CSHCN include seamless health care transitions for adolescents and young adults to the adult medical care system.77,78 Examples of successful transitions to adult care exist for specific complex and chronic medical conditions.79,–,81 Such models need to be applied and evaluated in a broader group of youth regardless of their underlying diagnostic condition.
CONCLUSIONS
CMC pose important challenges to families, providers, and our health care system that are qualitatively different from those of other populations of CSHCN. The development of novel complex care programs at multiple institutions suggests that traditional systems of care may not be meeting the substantial needs of such patients and their families. Although all CSHCN have unique and important needs, we believe that the coexistence of multiple family-identified service needs, chronic conditions, functional limitations, and extraordinarily high health care use that characterize these children demands a focused approach for this important subset of CSHCN. The creation of sustainable evidence-based models of care, using providers who are adequately trained and resourced to serve the needs of CMC, is essential for enhancing the quality of life and outcomes for these children.
Appendix
Clinical Examples of CMC
ACKNOWLEDGMENTS
Dr Cohen is supported by the Norman Saunders Complex Care Initiative at the Hospital for Sick Children. Dr Kuo is supported by the Arkansas Biosciences Institute, the Marion B. Lyon New Scientist Award, and the National Center for Research Resources (grant KL2RR029883). Dr Berry is supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grant K23 HD058092-01. Dr Simon is supported by National Institute of Neurological Disorders and Stroke Award K23 NS062900. Dr Srivastava is supported by NICHD career development award K23 HD052553 and in part by the Children's Health Research Center at the University of Utah and Primary Children's Medical Center Foundation.
We acknowledge the contributions of John Gordon, MD, Hema Patel, MD, David Hall, MD, Carl Tapia, MD, Allison Ballantine, MD, Linda Lindeke, RN, PhD, Sanjay Mahant, MD, and Nancy Murphy, MD, to the development of ideas described in and/or for critical review of this article.
Footnotes
- Accepted December 2, 2010.
- Address correspondence to Eyal Cohen, MD, MSc, FRCP(C), Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8. E-mail: eyal.cohen{at}sickkids.ca
The funders and sponsors were not involved in the design or conduct of the study or preparation, review, or approval of the manuscript.
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
- CSHCN =
- children with special health care needs •
- CCC =
- complex chronic condition •
- CMC =
- children with medical complexity •
- NS-CSHCN =
- National Survey of Children With Special Health Care Needs
REFERENCES
- 1.↵
- McPherson M,
- Arango P,
- Fox H,
- et al
- 2.↵
- Bethell CD,
- Read D,
- Blumberg SJ,
- Newacheck PW
- 3.↵
- Bramlett MD,
- Read D,
- Bethell C,
- Blumberg SJ
- 4.↵
- Davis MM,
- Brosco JP
- 5.↵
- Feudtner C,
- Feinstein JA,
- Satchell M,
- Zhao H,
- Kang TI
- 6.↵
- Lauver LS
- 7.↵
- Palfrey JS
- 8.↵
- Cady R,
- Finkelstein S,
- Kelly A
- 9.↵
- 10.↵
- Gordon JB,
- Colby HH,
- Bartelt T,
- Jablonski D,
- Krauthoefer ML,
- Havens P
- 11.↵
- Msall ME,
- Tremont MR
- 12.↵
- Tennant PW,
- Pearce MS,
- Bythell M,
- Rankin J
- 13.↵
- Wong LY,
- Paulozzi LJ
- 14.↵
- Hallahan AR,
- Shaw PJ,
- Rowell G,
- O'Connell A,
- Schell D,
- Gillis J
- 15.↵
- Magnani C,
- Pastore G,
- Coebergh JW,
- Viscomi S,
- Spix C,
- Steliarova-Foucher E
- 16.↵
- Hjern A,
- Lindblad F,
- Boman KK
- 17.↵
- Thompson JR,
- Carter RL,
- Edwards AR,
- et al
- 18.↵
- Glendinning C,
- Kirk S,
- Guiffrida A,
- Lawton D
- 19.↵
- 20.↵
- Stille CJ,
- Antonelli RC
- 21.↵
- Srivastava R,
- Stone BL,
- Murphy NA
- 22.↵
- Kelly A,
- Golnik A,
- Cady R
- 23.↵
- Cohen E,
- Friedman JN,
- Mahant S,
- Adams S,
- Jovcevska V,
- Rosenbaum P
- 24.↵
- Berman S,
- Rannie M,
- Moore L,
- Elias E,
- Dryer LJ,
- Jones MD Jr.
- 25.↵
- van der Lee J,
- Mokking L,
- Grooetnhuis M,
- Heymans H,
- Offringa M
- 26.↵
- Feudtner C,
- Christakis DA,
- Connell FA
- 27.↵World Health Organization. International Classification of Impairments, Disabilities and Handicaps: A Manual of Classification Relating to the Consequences of Diseases. Geneva, Switzerland: World Health Organization; 1980
- 28.↵World Health Organization. International Classification of Functioning, Disability and Health: Children and Youth Version (ICF-CY). Geneva, Switzerland: World Health Organization; 2007
- 29.↵
- Blumberg SJ,
- Welch EM,
- Chowdhury SR,
- Upchurch HL,
- Parker EK,
- Skalland BJ
- 30.↵
- Wang C,
- Guttmann A,
- To T,
- Dick PT
- 31.↵
- Simon TD,
- Berry J,
- Feudtner C,
- et al
- 32.↵
- Stein R,
- Jessop D
- 33.↵
- Law M,
- Rosenbaum P
- 34.↵
- Buescher PA,
- Whitmire JT,
- Brunssen S,
- Kluttz-Hile CE
- 35.↵
- Neff JM,
- Sharp VL,
- Muldoon J,
- Graham J,
- Myers K
- 36.↵
- Neff JM,
- Sharp VL,
- Muldoon J,
- Graham J,
- Popalisky J,
- Gay JC
- 37.↵
- 38.↵Institute of Medicine. Priority areas for national action: transforming health care quality. Available at: http://iom.edu/Reports/2003/Priority-Areas-for-National-Action-Transforming-Health-Care-Quality.aspx. Accessed June 17, 2010
- 39.↵
- Palfrey JS,
- Sofis LA,
- Davidson EJ,
- Liu J,
- Freeman L,
- Ganz ML
- 40.↵
- Cooley WC
- 41.↵
- Cooley WC,
- McAllister JW
- 42.↵
- Cooley WC,
- McAllister JW,
- Sherrieb K,
- Kuhlthau K
- 43.↵
- Gillette Y,
- Hansen NB,
- Robinson JL,
- Kirkpatrick K,
- Grywalski R
- 44.↵
- Stein RE,
- Jessop DJ
- 45.↵
- Jessop DJ,
- Stein RE
- 46.↵
- Jessop DJ,
- Stein RE
- 47.↵
- 48.↵
- Bergius H,
- Eng A,
- Fagerberg M,
- et al
- 49.
- Liddy C,
- Dusseault JJ,
- Dahrouge S,
- Hogg W,
- Lemelin J,
- Humbert J
- 50.↵
- Thomas CL,
- O'Rourke PK,
- Wainwright CE
- 51.↵
- Williams J,
- Sharp GB,
- Griebel ML,
- et al
- 52.↵
- Rahimy MC,
- Gangbo A,
- Ahouignan G,
- et al
- 53.↵
- Weiss KB
- 54.↵
- Strickland B,
- McPherson M,
- Weissman G,
- van Dyck P,
- Huang ZJ,
- Newacheck P
- 55.↵
- Wagner EH,
- Austin BT,
- Davis C,
- Hindmarsh M,
- Schaefer J,
- Bonomi A
- 56.↵
- Bodenheimer T,
- Wagner EH,
- Grumbach K
- 57.↵
- Coleman K,
- Austin BT,
- Brach C,
- Wagner EH
- 58.↵
- Edwards A,
- Elwyn G
- 59.↵
- Sacchetti A,
- Sacchetti C,
- Carraccio C,
- Gerardi M
- 60.↵
- Stone BL,
- Boehme S,
- Mundorff MB,
- Maloney CG,
- Srivastava R
- 61.↵
- Rappo PD
- 62.↵
- Srivastava R,
- Stone BL,
- Patel R,
- et al
- 63.↵
- Balaban RB,
- Weissman JS,
- Samuel PA,
- Woolhandler S
- 64.↵
- Criscione T,
- Walsh KK,
- Kastner TA
- 65.↵
- Liptak GS,
- Burns CM,
- Davidson PW,
- McAnarney ER
- 66.↵Institute of Medicine. Initial national priorities for comparative effectiveness research. Available at: www.iom.edu/Reports/2009/ComparativeEffectivenessvResearchPriorities.aspx. Accessed July 19, 2010
- 67.↵
- Wales PW,
- Diamond IR,
- Dutta S,
- et al
- 68.↵
- Srivastava R,
- Downey EC,
- O'Gorman M,
- et al
- 69.↵
- 70.↵
- Witt WP,
- Kasper JD,
- Riley AW
- 71.↵
- Wallander JL,
- Varni JW
- 72.↵
- Brehaut JC,
- Kohen DE,
- Raina P,
- et al
- 73.↵
- 74.↵
- Sabbeth BF,
- Leventhal JM
- 75.↵
- 76.↵
- 77.↵American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002;110(6 pt 2):1304–1306
- 78.↵
- Reiss J,
- Gibson R
- 79.↵
- Parker HW
- 80.↵
- Reid GJ,
- Irvine MJ,
- McCrindle BW,
- et al
- 81.↵
- Simon TD,
- Lamb S,
- Murphy NA,
- Hom B,
- Walker ML,
- Clark EB
- Copyright © 2011 by the American Academy of Pediatrics